Quantitative performance criteria 2015-16 Target 2016-17 Target 2017-18 Target 2018-19 Target 2019-20 Target Percentage of post-market reviews completed within scheduled timeframes. 90% 90% 90% 90% 90% Percentage of Government-accepted recommendations from post-market reviews that have been implemented within six months. 80% 80% 80% 80% 80% Program objective F. Monitoring the use of diagnostics, therapeutics and pathology Through the Quality Use of Diagnostics, Therapeutics and Pathology Fund (the Fund), the Australian Government supports the National Prescribing Service to provide information to consumers and health professionals on the quality use of medicines and medical testing. The Fund aims to improve health outcomes and assist the ongoing sustainability of the PBS and the Medicare Benefits Schedule (MBS). The Fund also supports the National Return and Disposal of Unwanted Medicines Program to collect consumers’ expired and unwanted medicines, and to help avoid accidental childhood poisoning and medication misuse. Qualitative performance criteria 2016-17 Reference or target Information regarding quality use of medicines is provided to health professionals and consumers to support use of therapeutics wisely, judiciously and safely to achieve better health and economic outcomes. The Department will provide funding for the provision of quality use of medicines information to be available in a variety of formats throughout the year, designed to support health professionals and consumers. Material changes to Program 4.3 resulting from the following measures: Health Flexible Funds – pausing indexation and achieving efficiencies Healthier Medicare – enhanced Medicare compliance program Table 2.4.5 – Performance Criteria for Program 4.4 Program 4.4: Private Health Insurance The Australian Government promotes affordable quality private health insurance, to provide greater choice for consumers. This will improve the sustainability of the health system as a Purpose Lead and shape Australia’s health and aged care systems and sporting outcomes through evidence-based policy, well targeted programs, and best practice regulation. Delivery Program activities, intended to benefit the Australian community, will be delivered under the following program objectives: A. Supporting the affordability of private health insurance through the private health insurance rebate B. Ensuring access to safe and effective medical devices through the Prostheses List C. Promoting a viable, sustainable and cost-effective private health insurance sector
C. Improving the quality of life for people with Epidermolysis Bullosa The National Epidermolysis Bullosa (EB) Dressing Scheme aims to improve the quality of life of patients with EB by improving the affordability of, and access to, clinically necessary dressings and other products for EB wounds. Quantitative performance criteria 2015-16 Target 2016-17 Target 2017-18 Target 2018-19 Target 2019-20 Target Number of people with Epidermolysis Bullosa receiving subsidised dressings. 135 180 185 190 195 Average time from receipt of an approved claim to delivery of aids and appliances. No increase on prior year No increase on prior year No increase on prior year No increase on prior year No increase on prior year Material changes to Program 4.8 resulting from the following measures: There are no material changes to Program 4.8 resulting from measures.